| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.279 | 90.852 | 81.960 | 0 | 0 | 397.044 | 977.777 | 999.189 | 461.966 | 484.744 |
| Total Income - EUR | 8.279 | 90.852 | 81.960 | 0 | 0 | 404.659 | 977.779 | 999.283 | 461.967 | 484.751 |
| Total Expenses - EUR | 1.143 | 15.756 | 8.094 | 3.904 | 3.627 | 172.632 | 225.486 | 154.407 | 183.243 | 201.177 |
| Gross Profit/Loss - EUR | 7.136 | 75.096 | 73.866 | -3.904 | -3.627 | 232.027 | 752.293 | 844.877 | 278.723 | 283.574 |
| Net Profit/Loss - EUR | 6.887 | 74.188 | 73.047 | -3.904 | -3.627 | 228.268 | 742.711 | 835.084 | 274.797 | 271.067 |
| Employees | 0 | 4 | 2 | 0 | 1 | 4 | 7 | 8 | 7 | 8 |
Check the financial reports for the company - Elytis Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 4.890 | 2.399 | 0 | 0 | 0 | 0 |
| Current Assets | 7.749 | 84.546 | 78.024 | 0 | 1.449 | 279.915 | 830.218 | 1.142.444 | 620.025 | 576.010 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.154 | 72.927 | 70.467 | 0 | 0 | 238.557 | 821.786 | 1.087.391 | 615.008 | 568.303 |
| Cash | 595 | 11.619 | 7.557 | 0 | 1.449 | 41.358 | 8.433 | 55.053 | 5.018 | 7.707 |
| Shareholders Funds | 5.230 | 74.243 | 73.136 | -3.853 | -7.405 | 221.003 | 742.759 | 835.133 | 500.907 | 543.022 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.519 | 10.303 | 4.888 | 3.853 | 13.745 | 61.311 | 87.459 | 307.311 | 119.118 | 32.988 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Elytis Laboratory S.r.l.